Evoke Pharma (EVOK) Tops Q2 EPS by 8c

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.52), $0.08 better than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Bristow Group to acquire Berry Aviation for $105 million
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits